Navamedic ASA (OSL:NAVA)
Norway · Delayed Price · Currency is NOK 16.35
0.00 (0.00%)
Aug 4, 2026, 11:12 AM CET
Navamedic ASA Financials Overview
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 571.24 | 565.36 | 531.44 | 512 | 382.14 | 278.44 |
Revenue Growth | 5.28% | 6.38% | 3.80% | 33.98% | 37.24% | 32.67% |
Gross Profit Gross Profit Growth | 218.22 | 217.57 | 205.52 | 198.37 | 163.52 | 111.74 |
Operating Income Operating Income Growth | 8.91 | 16.25 | 31.8 | 39.64 | 44.45 | 11.46 |
Net Income Net Income Growth | -16.2 | -23.54 | -5.49 | -13.69 | 29.43 | 0.62 |
Earnings Per Share EPS Growth | -0.79 | -1.24 | -0.31 | -0.79 | 1.73 | 0.04 |
EPS Growth | - | - | - | - | 4459.36% | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Norway Norway Growth | 194.83 | 201.65 | 214.12 | 198.89 | 138.05 |
Sweden Sweden Growth | 197.87 | 185.54 | 158.92 | 96.74 | 59.88 |
Denmark Denmark Growth | 51.21 | 38.86 | 38.07 | 28.15 | 27.61 |
Finland Finland Growth | 50.09 | 36.24 | 27.71 | 17.95 | 13.85 |
The Netherlands The Netherlands Growth | 49.13 | 34.75 | 54.01 | 26.37 | - |
Other countries Other countries Growth | 22.24 | 34.4 | 19.18 | 14.05 | 39.06 |
Total Total Growth | 565.36 | 531.44 | 512 | 382.14 | 278.44 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 67.1 | 74.16 | 37.29 | 38.04 | 55.3 | 52.62 |
Total Debt Total Debt Growth | 204.74 | 208.22 | 118.57 | 152.89 | 58.72 | 46.64 |
Net Cash (Debt) Net Cash Growth | -137.64 | -134.07 | -81.29 | -114.86 | -3.42 | 5.98 |
Net Cash Growth | - | - | - | - | - | -64.41% |
Net Cash Per Share Net Cash Per Share Growth | -6.72 | -7.04 | -4.65 | -6.65 | -0.20 | 0.36 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 14.21 | 25.59 | 39.35 | 2.18 | 17.94 | -1.3 |
Capital Expenditures CapEx Growth | -2.37 | -2.38 | -3.33 | -2.2 | -2.25 | -0.72 |
Free Cash Flow Free Cash Flow Growth | 11.85 | 23.2 | 36.03 | -0.02 | 15.69 | -2.02 |
Free Cash Flow Growth | -77.94% | -35.60% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 38.20% | 38.48% | 38.67% | 38.74% | 42.79% | 40.13% |
Operating Margin | 1.56% | 2.88% | 5.98% | 7.74% | 11.63% | 4.11% |
Pretax Margin | -1.96% | -2.77% | -0.30% | -1.20% | 11.12% | 0.85% |
Profit Margin | -2.84% | -4.16% | -1.03% | -2.67% | 7.70% | 0.22% |
FCF Margin | 2.07% | 4.10% | 6.78% | -0.00% | 4.11% | -0.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 20.43 | 899.28 |
Forward PE | - | 59.50 | 17.12 | 15.07 | 16.37 | - |
P/FCF Ratio | 33.10 | 24.60 | 12.60 | - | 38.32 | - |
PS Ratio | 0.69 | 1.01 | 0.85 | 1.24 | 1.57 | 2.00 |